Does Blue Cross Blue Shield of North Carolina Cover Ozempic?
The verdict
Conditional on most plans
BCBS of North Carolina covers Ozempic for type 2 diabetes with prior authorization — it does not cover Ozempic for off-label weight-loss use. North Carolina Medicaid (Tailored Care Management) publicly documented this exact distinction: it removed GLP-1 coverage for obesity effective October 1, 2025, while explicitly retaining Ozempic for type 2 diabetes. This state-level action is the clearest public-policy evidence in the cluster that an insurer/state can simultaneously end obesity GLP-1 coverage and maintain T2D coverage for the same molecule.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Blue Cross Blue Shield of North Carolina using your member ID.
Key facts
NC Medicaid removed GLP-1 obesity coverage effective October 1, 2025, while explicitly retaining Ozempic for type 2 diabetes — the clearest state-level separation of T2D and weight-loss coverage.
NC Medicaid / NC DHHS, GLP-1 Preferred Drug List update, October 2025
Ozempic is FDA-approved for type 2 diabetes glycemic control and cardiovascular risk reduction in T2D patients — not for weight loss.
FDA drug labeling (semaglutide injection)
The IRA Maximum Fair Price for semaglutide under Medicare is $274 per 30-day supply, effective January 1, 2027 — a 71% discount off the CY2024 list price of ~$959.
CMS, IRA Drug Price Negotiation Program, 2024
Medicare vs. commercial coverage
Whether Blue Cross Blue Shield of North Carolina covers Ozempic depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Medicare Advantage (Blue Medicare Advantage by BCBS NC): Ozempic is covered for type 2 diabetes with prior authorization. PA requires a documented T2D diagnosis and evidence of metformin step-therapy or a documented contraindication. The 2026 Part D out-of-pocket cap of $2,100 limits annual beneficiary spending on covered drugs. Medicare Advantage enrollees cannot use the NovoCare savings card — federal anti-kickback rules exclude Medicare and Medicaid beneficiaries. The IRA Maximum Fair Price for semaglutide (Ozempic/Rybelsus/Wegovy) is $274 per 30-day supply, effective January 1, 2027. Ozempic is not covered for weight loss under Medicare Advantage.
Commercial / Employer
Group & marketplace plans
Commercial/Employer: BCBS NC covers Ozempic for type 2 diabetes with prior authorization and metformin step-therapy. BCBS NC is the dominant commercial insurer in North Carolina. Formulary tier is not publicly confirmed at the drug level — verify on BCBS NC's drug-lookup tool. Commercially insured T2D patients may be eligible for the NovoCare Ozempic Savings Card ($25 per fill, max $150 per 28-day supply) — verify at NovoCare.com. Not covered for off-label weight loss. ACA/Individual: covered for T2D with PA; not covered for weight loss. Medicaid (NC Medicaid/Tailored Plans): Ozempic is explicitly retained for type 2 diabetes under NC Medicaid's October 1, 2025 policy change — the same action that removed obesity GLP-1 coverage. PA required; nominal Medicaid cost-share. This is publicly documented and represents the clearest state-level statement that T2D coverage and weight-loss exclusion coexist for the same molecule. Not covered for obesity/weight management under NC Medicaid. Medicaid enrollees cannot use the NovoCare savings card.
The 3 boxes you must tick to get approved
Commercial plans that will consider Ozempic require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 3 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Ozempic actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
~$1,028/month (Novo Nordisk published pricing, ~$1,027.51 for the 0.25/0.5 mg pen). NovoCare self-pay: ~$199/month intro price (first two fills through December 31, 2026), then ~$349/month (0.25/0.5/1 mg) or ~$499/month (2 mg).
List price with no coverage — before any manufacturer savings card.
With coverage
Commercial: plan-specific cost-share — not publicly confirmed; verify on BCBS NC drug-lookup tool. Medicare Advantage: cost-share depends on plan tier; $2,100 Part D OOP cap applies in 2026; IRA Maximum Fair Price of $274/30-day for semaglutide takes effect January 1, 2027. Medicaid (NC Tailored Plans): nominal Medicaid cost-share for T2D use.
Typical monthly copay once prior authorization is approved.
Bridge program
NovoCare Ozempic Savings Card: commercially insured T2D patients may pay as little as $25 per fill (max $150 per 28-day supply). Not available to Medicare, Medicaid, VA, DoD, or TRICARE beneficiaries. Verify eligibility at NovoCare.com.
Reduced copay through the assistance program, where eligible.
All figures are estimates — verify exact cost-share with BCBS NC member services or on BCBS NC's drug-lookup tool. Tier placement and cost-share vary by specific plan and line of business.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Look up Ozempic on BCBS NC's drug-lookup tool
Log in to your BCBS NC member account at bcbsnc.com and use the formulary or drug-lookup tool to confirm Ozempic's tier and any prior-authorization or step-therapy requirements on your specific plan. Commercial and Medicare Advantage plans have different formulary structures.
- 2
Have your prescriber submit the prior-authorization request
Ask your provider to submit a PA request to BCBS NC documenting: a T2D diagnosis (ICD-10 E11.x), evidence of metformin use or a documented contraindication. The clinical indication must be type 2 diabetes — not weight management. The NC Medicaid October 2025 policy explicitly retained T2D as a covered indication; BCBS NC commercial PA follows the same logic.
- 3
Confirm NC Medicaid T2D coverage if on a Tailored Plan
If you are enrolled in NC Medicaid through a Tailored Care Management plan, confirm current Ozempic T2D coverage with your Tailored Plan's member services. The October 2025 NC Medicaid policy retained T2D coverage while removing obesity coverage — verify your current plan formulary. If you are on BCBS NC commercial or Medicare Advantage, call BCBS NC member services for a cost estimate and tier confirmation.
Options if Blue Cross Blue Shield of North Carolina won't cover Ozempic
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Rybelsus (oral semaglutide)
Oral semaglutide tablet for type 2 diabetes. Also covered for T2D with PA on most formularies. Subject to the IRA Maximum Fair Price of $274/30-day effective January 1, 2027 for Medicare patients. Verify tier on BCBS NC drug-lookup.
Jardiance (empagliflozin)
SGLT-2 inhibitor commonly used as step-therapy before GLP-1 approval. Often at a lower cost-share tier than Ozempic on commercial and Medicaid formularies.
Metformin (generic)
First-line oral diabetes medication universally covered at low or no cost. Required as step therapy before Ozempic PA in most BCBS NC plans.
Compounded semaglutide (weight-loss seekers only)
For North Carolina patients seeking semaglutide for weight management — denied by BCBS NC commercial or ineligible under NC Medicaid's obesity GLP-1 removal — compounded semaglutide from $49/mo is available at getcurex.com/cl/glp without insurance. See the Curex offer section below for full disclaimers.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
No. BCBS NC does not cover Ozempic for weight loss under any plan. Ozempic holds FDA approval for type 2 diabetes and cardiovascular risk reduction in T2D patients — not for weight management. North Carolina reinforced this publicly: NC Medicaid removed GLP-1 obesity coverage effective October 1, 2025, while explicitly retaining Ozempic for T2D. The NC State Health Plan dropped GLP-1 weight-loss coverage in 2024. No NC insurer covers Ozempic for off-label weight-loss use.
NC Medicaid removed GLP-1 obesity coverage effective October 1, 2025 — but explicitly retained Ozempic for type 2 diabetes. These are two separate coverage tracks for the same molecule: T2D is an on-label, clinically supported indication that NC Medicaid kept; obesity treatment is an off-label use that was removed. If you are on NC Medicaid with a T2D diagnosis, Ozempic coverage with PA and nominal cost-share is retained. If you were seeking GLP-1 coverage for obesity through NC Medicaid, that coverage is not available.
Yes, BCBS NC covers Ozempic for type 2 diabetes with prior authorization across its commercial, ACA, Medicare Advantage, and NC Medicaid lines. Your prescriber must document a T2D diagnosis and metformin step-therapy or a contraindication. BCBS NC is the dominant commercial insurer in North Carolina; commercial formulary tier and cost-share are not publicly confirmed at the drug level — verify on BCBS NC's drug-lookup tool at bcbsnc.com or call member services.
The NC State Health Plan, which covers North Carolina state employees, dropped GLP-1 weight-loss drug coverage in 2024. This applies to weight-management indications only — state employees with type 2 diabetes seeking Ozempic for glycemic control are on a different coverage track. The NC State Health Plan is administered separately from BCBS NC commercial plans; state employees should verify their specific State Health Plan formulary for T2D coverage of Ozempic.
Commercially insured T2D patients on a BCBS NC commercial plan may be eligible for the NovoCare Ozempic Savings Card ($25 per fill, max $150 per 28-day supply) — verify eligibility at NovoCare.com. Medicare Advantage and NC Medicaid enrollees cannot use the savings card; federal anti-kickback rules exclude government program beneficiaries. If you are on a BCBS NC commercial plan with a confirmed T2D diagnosis, this card can significantly reduce out-of-pocket cost.
Related Articles
Does BCBS Michigan Cover Contrave? 2026 MI Guide | Curex
BCBS Michigan upheld weight-loss exclusions (DIFS 2025). Contrave is plan-dependent. MI Medicaid favors weight-loss GLP-1s; Contrave varies by PDL.
Read moreDoes BCBS North Carolina Cover Wegovy? 2026 | Curex
BCBS North Carolina: NC State Health Plan dropped weight-loss GLP-1s in 2024; NC Medicaid removed obesity coverage October 2025. Verify your specific plan.
Read moreDoes BCBS of Illinois Cover Jardiance? 2026
BCBS of Illinois (HCSC) covers Jardiance across commercial, ACA, Medicare, and Medicaid. Metformin-first step is common. 2026 MFP $197 for Medicare.
Read moreDoes BCBS Alabama Cover Wegovy? 2026 Guide | Curex
BCBS Alabama Wegovy coverage is employer-dependent and unpublished. Alabama Medicaid excludes obesity GLP-1s. How to verify your specific plan.
Read moreDoes Blue Cross Blue Shield of Minnesota Cover Mounjaro? 2026 | Curex
BCBS of Minnesota covers Mounjaro for type 2 diabetes with PA — not weight loss. MN Medicaid covers weight-loss GLP-1s for Zepbound, not Mounjaro.
Read moreDoes BCBS of North Carolina Cover Mounjaro? 2026 | Curex
BCBS NC covers Mounjaro for type 2 diabetes with prior auth — not weight loss. The NC Medicaid weight-loss GLP-1 churn never affected Mounjaro.
Read moreInsurance won't cover Ozempic for weight loss — here's a path that doesn't need it
BCBS of North Carolina does not cover Ozempic for weight loss — and NC Medicaid explicitly removed obesity GLP-1 coverage while retaining T2D coverage, drawing a clear policy line. For North Carolina patients seeking semaglutide for weight management without insurance coverage, Curex offers compounded semaglutide starting at $49/mo with no prior authorization needed. Compounded tirzepatide is also available from $149/mo. Compounded semaglutide is not the same medication as Ozempic or Wegovy. Prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Ozempic and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Blue Cross Blue Shield of North Carolina before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Ozempic and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.